176 related articles for article (PubMed ID: 10962865)
1. [P53 gene mutation in gallbladder cancer].
Roa I; Melo A; Roa J; Araya J; Villaseca M; de Aretxabala X
Rev Med Chil; 2000 Mar; 128(3):251-8. PubMed ID: 10962865
[TBL] [Abstract][Full Text] [Related]
2. [p53 gene mutation in cancer of the colon and rectum].
Roa JC; Roa I; Melo A; Araya JC; Villaseca MA; Flores M; Schneider B
Rev Med Chil; 2000 Sep; 128(9):996-1004. PubMed ID: 11349504
[TBL] [Abstract][Full Text] [Related]
3. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
4. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder.
Fujii K; Yokozaki H; Yasui W; Kuniyasu H; Hirata M; Kajiyama G; Tahara E
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):461-6. PubMed ID: 8781743
[TBL] [Abstract][Full Text] [Related]
5. Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile.
Yokoyama N; Hitomi J; Watanabe H; Ajioka Y; Pruyas M; Serra I; Shirai Y; Hatakeyama K
Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):297-301. PubMed ID: 9568784
[TBL] [Abstract][Full Text] [Related]
6. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
7. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
8. Alterations of p53 gene in gallbladder cancer patients of North India.
Nigam P; Misra U; Negi TS; Mittal B; Choudhuri G
Trop Gastroenterol; 2010; 31(2):96-100. PubMed ID: 20862982
[TBL] [Abstract][Full Text] [Related]
9. [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].
Muzeau F; Fléjou JF; Potet F; Belghiti J; Thomas G; Hamelin R
Gastroenterol Clin Biol; 1996; 20(5):430-7. PubMed ID: 8761140
[TBL] [Abstract][Full Text] [Related]
10. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
Hanada K; Itoh M; Fujii K; Tsuchida A; Ooishi H; Kajiyama G
Cancer; 1996 Feb; 77(3):452-8. PubMed ID: 8630951
[TBL] [Abstract][Full Text] [Related]
11. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
Zhang J; Zheng J; Fang W
Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779
[TBL] [Abstract][Full Text] [Related]
13. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.
Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A
Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291
[TBL] [Abstract][Full Text] [Related]
14. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.
Kamel D; Pääkkö P; Nuorva K; Vähäkangas K; Soini Y
J Pathol; 1993 May; 170(1):67-72. PubMed ID: 8100854
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic adenocarcinomas frequently show p53 gene mutations.
Scarpa A; Capelli P; Mukai K; Zamboni G; Oda T; Iacono C; Hirohashi S
Am J Pathol; 1993 May; 142(5):1534-43. PubMed ID: 8494051
[TBL] [Abstract][Full Text] [Related]
17. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium.
Tsai YY; Cheng YW; Lee H; Tsai FJ; Tseng SH; Chang KC
Mol Vis; 2005 Jan; 11():50-5. PubMed ID: 15682042
[TBL] [Abstract][Full Text] [Related]
18. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
[TBL] [Abstract][Full Text] [Related]
19. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]